Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

Search life-sciences literature (45,104,145 articles, preprints and more)

Search results

1-13 of 13 results

Sort by:

Relevance ^{Relevance: This is determined based on a ranking of criteria including term frequency, rarity of term, recency of article, whether there is a Title or Author field match, etc.}

Times cited

Date

Hesperidin, a Potential Antiviral Agent against SARS-CoV-2: The Influence of Citrus Consumption on COVID-19 Incidence and Severity in China.
Kowalczyk A
Medicina (Kaunas), 60(6):892, 28 May 2024
Cited by: 0 articles | PMID: 38929512
Add to export list Review
Novel Natural Inhibitors for Glioblastoma by Targeting Epidermal Growth Factor Receptor and Phosphoinositide 3-kinase.
Ullah A, Ullah S, Waqas M, Khan M, Rehman NU, Khalid A, Jan A, Aziz S, Naeem M, Halim SA, Khan A, Al-Harrasi A
Curr Med Chem, 31(40):6596-6613, 01 Jan 2024
Cited by: 1 article | PMID: 38616761
Add to export list
Antiviral Activity Against SARS-CoV-2 Variants Using in Silico and in Vitro Approaches.
Lee HJ, Choi H, Nowakowska A, Kang LW, Kim M, Kim YB
J Microbiol, 61(7):703-711, 26 Jun 2023
Cited by: 1 article | PMID: 37358709
Add to export list
In silico study of potential SARS-CoV-2 antagonist from Clitoria ternatea.
Chun CY, Khor SXY, Chia AYY, Tang YQ
Int J Health Sci (Qassim), 17(3):3-10, 01 May 2023
Cited by: 1 article | PMID: 37151745 | PMCID: PMC10155250
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Drug Potency Prediction of SARS-CoV-2 Main Protease Inhibitors Based on a Graph Generative Model.
Fadlallah S, Julià C, García-Vallvé S, Pujadas G, Serratosa F
Int J Mol Sci, 24(10):8779, 15 May 2023
Cited by: 0 articles | PMID: 37240128 | PMCID: PMC10218534
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Mutations in SARS-CoV-2 structural proteins: a global analysis.
Abavisani M, Rahimian K, Mahdavi B, Tokhanbigli S, Mollapour Siasakht M, Farhadi A, Kodori M, Mahmanzar M, Meshkat Z
Virol J, 19(1):220, 18 Dec 2022
Cited by: 33 articles | PMID: 36528612 | PMCID: PMC9759450
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
The Microalgal Diatoxanthin Inflects the Cytokine Storm in SARS-CoV-2 Stimulated ACE2 Overexpressing Lung Cells.
Sansone C, Pistelli L, Del Mondo A, Calabrone L, Fontana A, Noonan DM, Albini A, Brunet C
Antioxidants (Basel), 11(8):1515, 03 Aug 2022
Cited by: 6 articles | PMID: 36009234 | PMCID: PMC9405469
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Nanotechnology meets immunology towards a rapid diagnosis solution: the COVID-19 outbreak challenge.
B S A S S, J L R C, I C C, J M C C, B C L, G C F G, P H S M D, G M M M, F G F, J S A, A A P M, M F L, R L O, Z I P L, H S M
RSC Adv, 12(49):31711-31728, 04 Nov 2022
Cited by: 3 articles | PMID: 36380932 | PMCID: PMC9635439
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Ganoderma microsporum immunomodulatory protein acts as a multifunctional broad-spectrum antiviral against SARS-CoV-2 by interfering virus binding to the host cells and spike-mediated cell fusion.
Ho HPT, Vo DNK, Lin TY, Hung JN, Chiu YH, Tsai MH
Biomed Pharmacother, 155:113766, 28 Sep 2022
Cited by: 3 articles | PMID: 36271550 | PMCID: PMC9515347
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Computational exploration of the dual role of the phytochemical fortunellin: Antiviral activities against SARS-CoV-2 and immunomodulatory abilities against the host.
Agrawal S, Pathak E, Mishra R, Mishra V, Parveen A, Mishra SK, Byadgi PS, Dubey SK, Chaudhary AK, Singh V, Chaurasia RN, Atri N
Comput Biol Med, 149:106049, 08 Sep 2022
Cited by: 1 article | PMID: 36103744 | PMCID: PMC9452420
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
In silico screening of some compounds derived from the desert medicinal plant Rhazya stricta for the potential treatment of COVID-19.
Baeshen NA, Albeshri AO, Baeshen NN, Attar R, Karkashan A, Abbas B, Bouback TA, Aljaddawi AA, Refai MY, Abdelkader HS, Al Tamim A, Alowaifeer A, Ahmed F, Baeshen MN
Sci Rep, 12(1):11120, 01 Jul 2022
Cited by: 4 articles | PMID: 35778482 | PMCID: PMC9247940
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Drug repurposing against main protease and RNA-dependent RNA polymerase of SARS-CoV-2 using molecular docking, MM-GBSA calculations and molecular dynamics.
Mohammed AO, Abo-Idrees MI, Makki AA, Ibraheem W, Alzain AA
Struct Chem, 33(5):1553-1567, 27 Jun 2022
Cited by: 3 articles | PMID: 35789829 | PMCID: PMC9243907
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Structure based Drug Designing Approaches in SARS-CoV-2 Spike Inhibitor Design.
Shanmugam A, Venkattappan A, Gromiha MM
Curr Top Med Chem, 22(29):2396-2409, 01 Jan 2022
Cited by: 2 articles | PMID: 36330617
Add to export list Review

1-13 of 13 results

Search life-sciences literature (45,104,145 articles, preprints and more)

Search results

Hesperidin, a Potential Antiviral Agent against SARS-CoV-2: The Influence of Citrus Consumption on COVID-19 Incidence and Severity in China.

Novel Natural Inhibitors for Glioblastoma by Targeting Epidermal Growth Factor Receptor and Phosphoinositide 3-kinase.

Antiviral Activity Against SARS-CoV-2 Variants Using in Silico and in Vitro Approaches.

In silico study of potential SARS-CoV-2 antagonist from Clitoria ternatea.

Drug Potency Prediction of SARS-CoV-2 Main Protease Inhibitors Based on a Graph Generative Model.

Mutations in SARS-CoV-2 structural proteins: a global analysis.

The Microalgal Diatoxanthin Inflects the Cytokine Storm in SARS-CoV-2 Stimulated ACE2 Overexpressing Lung Cells.

Nanotechnology meets immunology towards a rapid diagnosis solution: the COVID-19 outbreak challenge.

Ganoderma microsporum immunomodulatory protein acts as a multifunctional broad-spectrum antiviral against SARS-CoV-2 by interfering virus binding to the host cells and spike-mediated cell fusion.

Computational exploration of the dual role of the phytochemical fortunellin: Antiviral activities against SARS-CoV-2 and immunomodulatory abilities against the host.

In silico screening of some compounds derived from the desert medicinal plant Rhazya stricta for the potential treatment of COVID-19.

Drug repurposing against main protease and RNA-dependent RNA polymerase of SARS-CoV-2 using molecular docking, MM-GBSA calculations and molecular dynamics.

Structure based Drug Designing Approaches in SARS-CoV-2 Spike Inhibitor Design.

Partnerships & funding